DK0671387T3 - Ny anvendelse af 1alfa-fluor-25-hydroxy-16-en-23-yn-cholecalciferol - Google Patents

Ny anvendelse af 1alfa-fluor-25-hydroxy-16-en-23-yn-cholecalciferol

Info

Publication number
DK0671387T3
DK0671387T3 DK95102749T DK95102749T DK0671387T3 DK 0671387 T3 DK0671387 T3 DK 0671387T3 DK 95102749 T DK95102749 T DK 95102749T DK 95102749 T DK95102749 T DK 95102749T DK 0671387 T3 DK0671387 T3 DK 0671387T3
Authority
DK
Denmark
Prior art keywords
hydroxy
cholecalciferol
fluoro
1alfa
new use
Prior art date
Application number
DK95102749T
Other languages
Danish (da)
English (en)
Inventor
Thomas I Doran
Shian-Jan Shiuey
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0671387T3 publication Critical patent/DK0671387T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK95102749T 1994-03-11 1995-02-27 Ny anvendelse af 1alfa-fluor-25-hydroxy-16-en-23-yn-cholecalciferol DK0671387T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08212453 US5384314B1 (en) 1994-03-11 1994-03-11 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol

Publications (1)

Publication Number Publication Date
DK0671387T3 true DK0671387T3 (da) 1998-10-07

Family

ID=22791087

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95102749T DK0671387T3 (da) 1994-03-11 1995-02-27 Ny anvendelse af 1alfa-fluor-25-hydroxy-16-en-23-yn-cholecalciferol

Country Status (22)

Country Link
US (1) US5384314B1 (cs)
EP (1) EP0671387B1 (cs)
JP (1) JP2659345B2 (cs)
KR (1) KR100360732B1 (cs)
CN (1) CN1051227C (cs)
AT (1) ATE165595T1 (cs)
AU (1) AU687972B2 (cs)
BR (1) BR9501035A (cs)
CA (1) CA2141652C (cs)
CZ (1) CZ288793B6 (cs)
DE (1) DE69502223T2 (cs)
DK (1) DK0671387T3 (cs)
ES (1) ES2116634T3 (cs)
FI (1) FI112323B (cs)
HU (1) HU219906B (cs)
IL (1) IL112887A0 (cs)
NO (1) NO307782B1 (cs)
NZ (1) NZ270624A (cs)
PH (1) PH31333A (cs)
PL (1) PL179120B1 (cs)
RU (1) RU2142803C1 (cs)
ZA (1) ZA951798B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US5696103A (en) * 1995-11-17 1997-12-09 Syntex (U.S.A.) Inc. Method for treating osteoporosis
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
US5840718A (en) * 1997-03-06 1998-11-24 Hoffmann-La Roche Inc. 22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
DE69813380T2 (de) * 1997-05-02 2003-12-04 Duphar International Research B.V., Weesp Verfahren zur Herstellung von 16-Dehydro Vitamin D Verbindungen
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US5919986A (en) * 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE10211555A1 (de) * 2002-03-15 2003-10-02 Imtm Inst Fuer Medizintechnolo Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit sebozytärer Hyperproliferation und veränderten Differenzierungszuständen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3571643A (en) * 1967-09-20 1971-03-23 Sony Corp Plural beam electron gun for a color picture tube with different-sized control grid apertures
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
JPS6340975A (ja) * 1986-08-05 1988-02-22 Mitsubishi Electric Corp 階調補正方式
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
ATE141914T1 (de) * 1992-05-20 1996-09-15 Hoffmann La Roche Fluorierte analoge vitamins d3

Also Published As

Publication number Publication date
HU9500666D0 (en) 1995-04-28
ATE165595T1 (de) 1998-05-15
CA2141652C (en) 2006-05-09
HUT70746A (en) 1995-10-30
CN1112918A (zh) 1995-12-06
PL307629A1 (en) 1995-09-18
PL179120B1 (pl) 2000-07-31
FI951134A0 (fi) 1995-03-10
DE69502223D1 (de) 1998-06-04
AU1364495A (en) 1995-09-21
NO950920L (no) 1995-09-12
CA2141652A1 (en) 1995-09-12
CZ288793B6 (cs) 2001-09-12
IL112887A0 (en) 1995-06-29
EP0671387B1 (en) 1998-04-29
KR100360732B1 (ko) 2003-03-04
DE69502223T2 (de) 1998-10-29
RU95103438A (ru) 1997-02-10
NO950920D0 (no) 1995-03-10
US5384314A (en) 1995-01-24
ZA951798B (en) 1996-08-14
NO307782B1 (no) 2000-05-29
AU687972B2 (en) 1998-03-05
JP2659345B2 (ja) 1997-09-30
EP0671387A1 (en) 1995-09-13
RU2142803C1 (ru) 1999-12-20
FI112323B (fi) 2003-11-28
KR950032046A (ko) 1995-12-20
BR9501035A (pt) 1995-10-31
JPH07258208A (ja) 1995-10-09
US5384314B1 (en) 1997-08-05
CN1051227C (zh) 2000-04-12
HU219906B (hu) 2001-09-28
FI951134L (fi) 1995-09-12
PH31333A (en) 1998-07-06
CZ63295A3 (en) 1995-11-15
ES2116634T3 (es) 1998-07-16
NZ270624A (en) 1996-06-25

Similar Documents

Publication Publication Date Title
DK0772600T3 (da) 1,2-substituerede imidazolylforbindelser til behandling af inflammation
DK0671387T3 (da) Ny anvendelse af 1alfa-fluor-25-hydroxy-16-en-23-yn-cholecalciferol
DE69737592D1 (de) Mittel gegen juckreiz
BR9709427A (pt) Oxa ácidos e compostos relacionados para tratamento de condições da pele
ES2134847T3 (es) Derivados de taxol.
IL138402A0 (en) Heterocyclically substituted amides used as calpain inhibitors
ATE253063T1 (de) 5-ht1f-agonisten
AU6894800A (en) Caspase inhibitors and uses thereof
TR199900856T2 (xx) Bron�la ilgili terapi maddeleri olarak benzonaftiridinler
KR970074763A (ko) 불소화된 비타민 d₃ 유사체
DE69825980D1 (de) 4,5-dihydroxy-2-cyclopentene-1-on für die behandlung von rheumatismus, entzündungen und autoimmunerkrankungen
TW235294B (cs)
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs
BR9812671A (pt) Tetrahidrofurano fosfato- e hidróxi ésteres, como pró-medicamentos para o correspondente agente antifúgico
TW232007B (cs)
AU2003207024A1 (en) Spermidine derivatives for the treatment of chronic neurodegenerative diseases
PT930879E (pt) Utilizacao de dobesilato de calcio para a preparacao de um medicamento para o tratamento de retardamento embrionario
ATE12582T1 (de) Mittel zur krebsbehandlung.
MY121344A (en) Formulated product
BR9915371A (pt) Processos para a preparação de um composto de 1, 4-diaril-2-fluoro-1, 3-butadieno e de um composto de 1, 4-diaril-2-fluoro-2-buteno